arrow
L

Lei Qian

physical education school
H指数:27
被引数:2,719

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of picankibart in patients with moderately to severely active ulcerative colitis: a randomised, double-blind, placebo-controlled phase 2 trial

帕坎库巴特治疗中度至重度活动性溃疡性结肠炎的疗效与安全性:一项随机、双盲、安慰剂对照的2期临床试验

2026-01-010
PRE
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes

Mazdutide 与 dulaglutide 在中国2型糖尿病成人中的比较

Nature
IF48.5
2025-12-170
PRE
Mazdutide versus placebo in Chinese adults with type 2 diabetes

Mazdutide 与安慰剂在中国 2 型糖尿病成人中的比较

Nature
IF48.5
2025-12-170
PRE
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial

Mazdutide 与 Semaglutide 治疗 2 型糖尿病及肥胖:DREAMS-3 期 3 临床试验的背景、设计与基线数据

2025-11-011
PRE
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial

Efdamrofusp alfa与Aflibercept在新生血管性年龄相关性黄斑变性患者中的疗效与安全性:一项随机、双盲、活性对照、非劣效性、II期临床试验

2025-02-010
PRE
HiFAST: An Hi data calibration and imaging pipeline for FAST
2024-04-1217
OA